Marcus Ruscetti to Killer Cells, Natural
This is a "connection" page, showing publications Marcus Ruscetti has written about Killer Cells, Natural.
Connection Strength
1.724
-
Chowdhury SR, Murphy KC, Parikh CN, DeMarco KD, Zhou L, Ruscetti M. Measuring the impact of therapy-induced senescence on NK cell phenotypes in cancer. Methods Cell Biol. 2024; 190:171-201.
Score: 0.772
-
Ruscetti M, Leibold J, Bott MJ, Fennell M, Kulick A, Salgado NR, Chen CC, Ho YJ, Sanchez-Rivera FJ, Feucht J, Baslan T, Tian S, Chen HA, Romesser PB, Poirier JT, Rudin CM, de Stanchina E, Manchado E, Sherr CJ, Lowe SW. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 2018 12 21; 362(6421):1416-1422.
Score: 0.521
-
Parikh CN, DeMarco KD, Bhalerao N, Giwa HK, Kane GI, Dinnell RW, Ma B, Mori H, Brassil ML, Murphy KC, Zhao Z, Johnson C, Ramani S, Zhou L, Chibaya L, Qiao Y, Hu K, Zhu LJ, Lewis BC, Xue W, Pitarresi JR, Atukorale PU, Ruscetti M. Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer. Nat Commun. 2026 Jun 19; 17(1).
Score: 0.219
-
Chava S, Bugide S, Malvi P, DeMarco KD, Ma B, Parikh CN, Ruscetti M, Zajac A, Cai G, Gupta R, Wajapeyee N. Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-?1 suppression. EMBO Mol Med. 2026 01; 18(1):232-274.
Score: 0.211